Skip to content Skip to footer
Subscribe Now
ThoughtSpot_Saurabh Chaubey5
THOUGHTSPOT

4 Biopharma Trends to Watch out in 2024

Shots: 2023 had been a great year for the biopharma industry despite several imposed restrictions from the IRA and inflation With several swaying factors impacting the biopharma industry, including social, economic, regulatory and others, some of the noteworthy trends that emerged in 2024 and are shaping the ways biopharma companies operate The article explores four key…
July 9, 2024

Read more

Viewpoints_Jesse Mendelsohn
VIEWPOINTS

Drug Pricing & Rebate Management: Jesse Mendelsohn from Model N in Dialogue Exchange with PharmaShots

Shots: Drug pricing reforms from the IRA continue to impact pharmaceutical companies. The rebates ensued from the IRA guidelines are heavily affecting the revenues of biopharma companies Today, at PharmaShots we have Jesse Mendelsohn, Sr. Vice President at Model N shedding light on the company’s recently launched solution called Medicare Part D inflation rebate-per-unit With…
July 1, 2024

Read more